Clinical Study Of Blood Circulation Pinggan Yang Treatment Migraine Without Aura Remission(Hyperactivity Laden Blood Stasis Type)

Objective: To observe Xiongma capsule treatment of migraine without aura remission of clinical efficacy(hyperactivity laden blood stasis), evaluation calming liver yang, blood circulation treatment of migraine without aura remission(hyperactivity laden blood stasis) of clinical effectiveness.Methods: This study used Xiongma pill capsules with placebo, 60 patients screened Changchun University of Traditional Chinese Medicine clinic encephalopathy migraine treatment group and the control group of 30 patients were randomized, double-blind, placebo-controlled clinical trial design method. 12 weeks of treatment.Results: The treatment group Xiongma capsule treatment of migraine without aura remission(hyperactivity embrace stasis syndrome) halved the number of attacks was 86%, significantly higher than in reducing headache frequency, duration, pain degree, the difference between the two groups before treatment, no, there was a significant difference between the treatment groups, the treatment group than the placebo group. In terms of improving TCM syndrome, after statistical analysis concluded that the treatment group, the total efficiency of 90% in the control group, the total efficiency of 63%, there was a significant difference(P <0.05) groups, with statistical significance, indicating In terms of improving the TCM syndromes Xiongma capsule group was superior to the placebo group. During the test patients were no significant adverse events and side effects of drugs.Conclusion: Xiongma capsule treatment of migraine without aura remission(hyperactivity laden blood stasis) in headache frequency rate by half, reduce the number of migraine attacks, the extent, duration and TCM syndrome were significantly superior to placebo in improving aspects group, it follows calming liver yang, blood circulation treatment of migraine without aura remission(hyperactivity embrace stasis syndrome) is valid.